We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
ConocoPhillips
COP
$147B
| $3.64M | 0.06% |
+51,720
| New | +$3.46M |
|
|
RTN
302
DELISTED
Raytheon Company
RTN
| $3.62M | 0.06% |
36,645
+14,790
| +68% | +$1.4M |
|
303
SouthState Bank Corp
SSB
$10.3B
| $3.61M | 0.06% |
+57,645
| New | +$3.58M |
|
304
Regions Financial
RF
$26.3B
| $3.59M | 0.06% |
323,440
+303,340
| +1,509% | +$3.2M |
|
|
XL
305
DELISTED
XL Group Ltd.
XL
| $3.57M | 0.06% |
114,110
+60,600
| +113% | +$1.81M |
|
|
HSNI
306
DELISTED
HSN, Inc.
HSNI
| $3.54M | 0.06% |
59,240
+38,180
| +181% | +$2.22M |
|
|
AFFX
307
DELISTED
Affymetrix Inc
AFFX
| $3.53M | 0.06% |
495,305
-79,900
| -14% | -$644K |
|
308
Everest Group
EG
$15.2B
| $3.52M | 0.06% |
+23,010
| New | +$3.4M |
|
|
AYR
309
DELISTED
Aircastle Ltd
AYR
| $3.5M | 0.06% |
180,511
-116,321
| -39% | -$2.22M |
|
310
Aflac
AFL
$63.9B
| $3.48M | 0.06% |
110,520
+37,100
| +51% | +$1.18M |
|
311
Ball Corp
BALL
$17B
| $3.45M | 0.06% |
125,868
-21,000
| -14% | -$557K |
|
|
RAI
312
DELISTED
Reynolds American Inc
RAI
| $3.4M | 0.06% |
+127,240
| New | +$3.2M |
|
313
BOK Financial
BOKF
$8.64B
| $3.38M | 0.06% |
48,932
-10,432
| -18% | -$683K |
|
|
SYNT
314
DELISTED
Syntel Inc
SYNT
| $3.33M | 0.06% |
74,122
+49,802
| +205% | +$2.24M |
|
315
Greif
GEF
$4.47B
| $3.31M | 0.06% |
63,026
-78,218
| -55% | -$4.02M |
|
|
NEWP
316
DELISTED
NEWPORT CORP
NEWP
| $3.27M | 0.05% |
158,075
+42,200
| +36% | +$820K |
|
317
Textron
TXT
$16.6B
| $3.26M | 0.05% |
83,080
+66,230
| +393% | +$2.48M |
|
318
Monster Beverage
MNST
$91.4B
| $3.24M | 0.05% |
+279,600
| New | +$3.27M |
|
|
UIL
319
DELISTED
UIL HOLDINGS
UIL
| $3.24M | 0.05% |
+87,900
| New | +$3.31M |
|
320
Commerce Bancshares
CBSH
$8.5B
| $3.23M | 0.05% |
125,080
-44,932
| -26% | -$1.12M |
|
|
SKUL
321
DELISTED
SKULLCANDY INC
SKUL
| $3.17M | 0.05% |
345,867
+105,451
| +44% | +$855K |
|
322
Quad
QUAD
$430M
| $3.12M | 0.05% |
133,087
+110,150
| +480% | +$2.63M |
|
323
iShares Russell 2000 Value ETF
IWN
$14.4B
| $3.07M | 0.05% |
30,480
-4,390
| -13% | -$433K |
|
324
American States Water
AWR
$3.39B
| $3.06M | 0.05% |
94,907
-136,838
| -59% | -$4.01M |
|
325
Texas Roadhouse
TXRH
$12.7B
| $3.05M | 0.05% |
117,050
-64,750
| -36% | -$1.67M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.